734-936-8000 - Service Desk | Request Support

M&M: The First 30 Days of COVID-19 at Michigan Medicine

To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.

Step Status
Educational Materials
Evaluation
Release Date: Fri, 4/10/20
Termination Date: Thu, 12/31/20
Credits: 1
Description:

M&M: The First 30 Days of COVID-19 at Michigan Medicine

Presenter: Molly Tokaz, MD

This lecture was originally presented during Internal Medicine Grand Rounds on 3/27/20.
There are no relevant financial relationships to disclose for this activity.


This activity is for Michigan Medicine only.
Target Audience: This activity is for House Officers, Medical Students, Nurse Practitioners, Nurses, Physician Assistants, Physicians.
Accreditation Information:

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Info:

Arentz M, Yim E, Klaff L, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. Published online March 19, 2020. doi:10.1001/jama.2020.4326 Article

Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. Published online March 23, 2020. doi:10.1001/jama.2020.4683 Article

Zhou, Fei et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, Volume 395, Issue 10229, 1054 – 1062 Article

Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271. doi:10.1038/s41422-020-0282-0 Article

WHO Joint Commission Final Report on COVID-19. 2020 Article

Categories: COVID

Credits available:

AMA PRA Category 1: 1.00
Participation: 1.00